CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8,790 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01549340
NCT01549340N/ACompleted
CompareCT.gov

Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy

ALK-Abelló A/S·observational·Posted Mar 9, 2012·Updated Mar 3, 2017

In Brief

An observational study for Perennial Allergic Rhinitis and Seasonal Allergic Rhinitis. Completed, enrolled 8,790 participants.

Detailed Summary

The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy (AIT) upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPerennial Allergic Rhinitis, Seasonal Allergic Rhinitis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 9, 2012
Enrollment StartNov 1, 2011
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.3 years ago